Anthropic CEO Dario Amodei addresses AI trust crisis

Anthropic CEO Dario Amodei has addressed a growing crisis of trust regarding technology companies, governments, and the artificial intelligence sector. Amodei acknowledged that AI companies, including Anthropic, have yet to fully deliver on the significant promises made to benefit humanity, noting that public skepticism is often rooted in decades of social media influence and the concentrated power of tech firms.

To rebuild credibility, Amodei argues that the industry must move beyond marketing and grandiloquent promises, focusing instead on concrete results. He suggested that achieving a milestone as significant as curing cancer could be a way to restore public confidence. Amodei stated that simply claiming AI will revolutionize medicine is insufficient and can be perceived as misleading or a cliché.

Anthropic is currently intensifying its efforts in the fields of biology and medicine. Amodei expressed an ambitious vision for the sector, suggesting that accelerated technological development could potentially allow for the treatment of most human diseases within five to ten years, though he noted such a timeline may be difficult for specialists to believe.